Skip to content
10-Q/A

Quarterly Report

WEIKANG BIO-TECHNOLOGY GROUP CO., INC.

0001144204-11-051002

← back to feed
Filed
Sep 1, 2011 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2011 · Aug 11, 2011 30.99M sh
Stockholders Equity Q2 2011 · Jun 30, 2011 $88.41M
Current Liabilities Q2 2011 · Jun 30, 2011 $4.02M
Current Liabilities Q2 2011 · Dec 31, 2010 $8.21M
Total Liabilities Q2 2011 · Jun 30, 2011 $7.52M
Total Liabilities Q2 2011 · Dec 31, 2010 $11.68M
Current Assets Q2 2011 · Jun 30, 2011 $69.73M
Current Assets Q2 2011 · Dec 31, 2010 $52.55M
Total Assets Q2 2011 · Jun 30, 2011 $95.93M
Total Assets Q2 2011 · Dec 31, 2010 $78.61M
Shares Diluted Q2 2011 · Jun 30, 2010 28.02M sh
Shares Diluted Q2 2011 · Jun 30, 2010 27.69M sh
Capex Q2 2011 · Jun 30, 2010 $8.87K
Operating Cash Flow Q2 2011 · Jun 30, 2010 $7.23M
Cash And Equivalents Q2 2011 · Jun 30, 2010 $20.49M
Cash And Equivalents Q2 2011 · Dec 31, 2009 $11.38M
Eps Diluted Q2 2011 · Jun 30, 2010 $0.07
Eps Diluted Q2 2011 · Jun 30, 2010 $0.23
Eps Basic Q2 2011 · Jun 30, 2010 $0.07
Eps Basic Q2 2011 · Jun 30, 2010 $0.23
Sga Expense Q2 2011 · Jun 30, 2010 $1.43M
Sga Expense Q2 2011 · Jun 30, 2010 $2.62M
Rd Expense Q2 2011 · Jun 30, 2010 $732.58K
Rd Expense Q2 2011 · Jun 30, 2010 $802.91K
Net Income Q2 2011 · Jun 30, 2010 $1.92M
Net Income Q2 2011 · Jun 30, 2010 $6.46M
Operating Income Q2 2011 · Jun 30, 2010 $2.86M
Operating Income Q2 2011 · Jun 30, 2010 $9.22M
Gross Profit Q2 2011 · Jun 30, 2010 $6.12M
Gross Profit Q2 2011 · Jun 30, 2010 $14.44M
Cost Of Revenue Q2 2011 · Jun 30, 2010 $4.37M
Cost Of Revenue Q2 2011 · Jun 30, 2010 $10.01M
Revenue Q2 2011 · Jun 30, 2010 $10.49M
Revenue Q2 2011 · Jun 30, 2010 $24.45M